Reporte zur Charge UJ191AAA

Symptomtext

eczema; Initial information received on 17-Feb-2021 regarding an unsolicited valid non-serious case received from a other health professional. This case involves female patient of an unknown age who experienced eczema, while she received vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL]. Medical history, medical treatment, vaccination and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for Immunisation; and ROTAVIRUS VACCINE (ROTAVIRUS VACCINE) for Immunisation. On an unknown date, the patient received a standard dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (lot UJ191AAA and expiry date: 22-Feb-2022) via an unknown route in the left thigh for prophylactic vaccination. On an unknown date, the patient developed a non-serious eczema (unknown latency) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE. Details of laboratory data not reported. It was not reported if the patient received a corrective treatment. At the time of reporting, the outcome of event was reported as unknown.